Telo Genomics Corp. (FRA:3D0A)

Germany flag Germany · Delayed Price · Currency is EUR
0.0010
-0.0185 (-94.87%)
At close: Nov 28, 2025
-98.31%
Market Cap3.10M
Revenue (ttm)n/a
Net Income (ttm)-1.66M
Shares Outn/a
EPS (ttm)-0.02
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volumen/a
Open0.0010
Previous Close0.0195
Day's Range0.0010 - 0.0010
52-Week Range0.0010 - 0.0795
Betan/a
RSI44.01
Earnings DateNov 17, 2025

About Telo Genomics

Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions, primarily in Canada. The company’s TeloView platform measures the 3D structure and spatial organization of telomeres to inform on genetic and molecular characteristics that are predictive of genomic instability, identify specific disease mechanisms, predict disease risks, and determine effective treatments. Its lead product is TeloView-SM... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
CEO Sabine Mai
Country Canada
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 3D0A
Full Company Profile

Financial Performance

Financial numbers in CAD Financial Statements

News

There is no news available yet.